Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21042,854,1.04 [0.95-1.14],0.4033794800686545
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21008,169,1.01 [0.82-1.25],0.9029409670319828
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22727,172,1.06 [0.87-1.30],0.5664845998930205
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16021,641,1.04 [0.93-1.16],0.4816301414131547
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22666,111,0.87 [0.67-1.12],0.282272290991535
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21774,75,0.92 [0.68-1.26],0.613485742445683
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23879,110,0.88 [0.68-1.13],0.3187179625204653
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23871,73,0.86 [0.63-1.18],0.3517018181791524
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21223,51,1.09 [0.75-1.58],0.6556074387944715
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23324,104,1.01 [0.78-1.31],0.951266842672846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23284,64,0.90 [0.64-1.25],0.5241218128813502
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23946,69,1.16 [0.85-1.60],0.3448612155233921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23923,85,0.97 [0.73-1.30],0.8551700354371836
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23920,82,0.97 [0.72-1.30],0.8136872470675257
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,23627,57,1.09 [0.77-1.55],0.6146421893307076
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22930,371,1.04 [0.91-1.20],0.5535266923370024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22675,116,1.23 [0.97-1.57],0.0916914835897849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22815,256,1.01 [0.85-1.19],0.9110913095443456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19577,46,0.78 [0.52-1.17],0.2336523078102376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19589,58,nan [nan-nan],
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19758,227,1.02 [0.86-1.22],0.7915075657234529
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19765,234,1.01 [0.85-1.21],0.8723084074757708
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20109,578,1.00 [0.89-1.11],0.9515402104791328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19578,47,1.10 [0.75-1.62],0.6339736786993472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21511,895,1.15 [1.05-1.26],0.0019948952341312
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23031,256,1.13 [0.96-1.34],0.1472629856962801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23645,99,1.09 [0.84-1.43],0.5109145916521047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24032,80,1.07 [0.79-1.43],0.6765071572446055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,23843,56,1.52 [1.07-2.14],0.0177494889768519
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24029,59,0.71 [0.50-1.01],0.06012171879036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Stomach,24074,45,0.71 [0.48-1.07],0.101959098855761
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,23885,246,0.87 [0.73-1.03],0.100579351827808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24030,100,0.82 [0.63-1.08],0.15761010139286
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24031,93,0.83 [0.63-1.10],0.1928149928304205
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23963,64,0.84 [0.60-1.17],0.3048364667770024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",23965,63,0.86 [0.62-1.21],0.3987957056561436
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,23883,235,1.06 [0.89-1.26],0.512042403391978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24032,110,1.25 [0.97-1.60],0.0827103395200542
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,23933,196,1.10 [0.91-1.33],0.3186774907292639
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of breast,24017,120,0.91 [0.72-1.17],0.4685722606441989
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,23583,871,0.99 [0.90-1.09],0.8294795243915463
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22879,235,1.15 [0.97-1.37],0.1137223215004389
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22650,389,1.21 [1.06-1.38],0.0057426422778887
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22650,389,1.21 [1.06-1.38],0.0057426422778887
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21316,345,1.11 [0.96-1.28],0.1729148963771696
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23553,86,0.84 [0.63-1.12],0.2352911527923553
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23777,86,1.02 [0.77-1.36],0.8726752868339557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20000,775,1.18 [1.07-1.30],0.0012112251686984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22084,761,1.06 [0.96-1.17],0.2574104779293258
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22458,94,0.87 [0.66-1.15],0.3237877486351699
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23188,48,0.98 [0.67-1.44],0.9192033648598216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22448,84,0.92 [0.69-1.24],0.594154475010995
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22717,353,1.24 [1.07-1.43],0.0044951916484773
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22707,343,1.25 [1.08-1.44],0.0034307951783175
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22295,162,1.02 [0.81-1.29],0.8372609290562323
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22297,159,1.04 [0.82-1.31],0.74912299944543
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19830,605,1.15 [1.03-1.29],0.0151858920032845
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19293,68,1.18 [0.86-1.64],0.3071776082693956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19787,562,1.15 [1.02-1.29],0.0180806955351858
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19272,47,1.43 [0.98-2.10],0.0640693470298282
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19284,59,1.31 [0.93-1.85],0.116942834786859
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,20326,530,1.03 [0.91-1.16],0.6437700994896004
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19897,101,0.93 [0.71-1.22],0.6114155412705613
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23857,65,0.79 [0.56-1.10],0.1625585756021829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23894,39,0.73 [0.47-1.13],0.1582300436938047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22810,33,0.87 [0.54-1.40],0.571644949753239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24029,33,0.86 [0.54-1.37],0.5248040434698951
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19829,33,0.88 [0.55-1.41],0.5941174218394312
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Alcohol dependence,22801,24,0.71 [0.40-1.26],0.2444430896314956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,22717,32,1.04 [0.64-1.68],0.8885647980680833
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19835,39,0.99 [0.64-1.52],0.9516748388953304
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20121,325,1.04 [0.90-1.21],0.5731977560223239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Depression,22328,290,1.03 [0.88-1.21],0.7061956850443446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Depression or dysthymia,19940,251,1.08 [0.91-1.27],0.3989795881745726
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19926,130,1.17 [0.93-1.48],0.1817012478174436
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Other anxiety disorders,22410,66,0.88 [0.63-1.23],0.4551216866973151
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,20856,1422,1.07 [0.99-1.15],0.0889114389429611
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19083,170,1.08 [0.89-1.33],0.4315012536438621
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23899,139,1.06 [0.84-1.32],0.6275813146622524
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22931,367,1.06 [0.92-1.22],0.4073402647343426
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,22679,115,1.04 [0.81-1.34],0.7442117688104736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,22673,109,1.17 [0.91-1.51],0.2170135098310203
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23685,101,1.19 [0.92-1.55],0.188987022356312
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23470,51,1.26 [0.87-1.82],0.2215781914622674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,22652,88,0.97 [0.73-1.30],0.8553527866645405
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,23716,63,0.98 [0.70-1.38],0.9104001447349632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22872,735,1.00 [0.90-1.10],0.9682191798000112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22242,105,1.09 [0.84-1.41],0.5261816794313303
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22599,462,1.01 [0.89-1.15],0.8687451396571069
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23850,67,1.22 [0.89-1.68],0.2220919447629907
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,23834,51,1.11 [0.76-1.60],0.5919367147278928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,23652,103,0.97 [0.74-1.26],0.7974100836745162
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23434,372,1.02 [0.89-1.18],0.7433815593529072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23276,214,1.10 [0.92-1.32],0.3074122220676898
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23126,64,0.75 [0.53-1.05],0.092589795294666
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23176,114,1.13 [0.88-1.45],0.3254722487063962
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23154,92,1.20 [0.91-1.57],0.2016976733655344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20429,151,1.06 [0.85-1.32],0.5918071814099972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20639,361,1.03 [0.89-1.18],0.7254295476951069
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23162,151,1.08 [0.87-1.34],0.4834281120858646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23847,29,1.10 [0.67-1.80],0.710240050437027
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1551,29,1.02 [0.61-1.72],0.9389199178085922
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22325,29,1.11 [0.68-1.82],0.6671907109354233
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23465,79,1.21 [0.90-1.63],0.2021242836690294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23428,42,1.40 [0.94-2.08],0.1022289385102913
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23331,78,0.87 [0.64-1.18],0.3594412676951973
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23564,90,0.93 [0.70-1.24],0.6347952913840511
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23961,110,1.10 [0.86-1.42],0.4467066932233612
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23379,96,1.06 [0.81-1.39],0.6574291706575253
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17691,2410,1.10 [1.04-1.18],0.0023484875448106
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23581,70,0.95 [0.69-1.31],0.766977809241973
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18607,1766,1.12 [1.05-1.21],0.0014890101814365
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,18623,1782,1.12 [1.04-1.20],0.0018035377510576
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16875,34,1.14 [0.72-1.81],0.5630472649772538
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22614,623,1.09 [0.98-1.22],0.1157286682346665
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,22421,430,1.09 [0.95-1.24],0.2225600146326379
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23491,122,0.96 [0.75-1.23],0.7481552429431967
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23559,190,1.03 [0.85-1.25],0.7523334928952383
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24011,25,1.32 [0.78-2.21],0.2995661496630367
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22072,81,1.10 [0.82-1.48],0.5121046475289142
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22385,405,1.09 [0.95-1.25],0.1985188177087414
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23372,87,1.12 [0.84-1.49],0.4481861696075352
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23472,190,1.14 [0.94-1.39],0.1768044726657549
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23376,91,0.81 [0.61-1.07],0.1420072749789943
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23376,91,0.81 [0.61-1.07],0.1420072749789943
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16929,88,0.84 [0.63-1.12],0.2366111512815717
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20949,32,1.29 [0.80-2.06],0.2942296433420474
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,20983,66,1.20 [0.87-1.66],0.2729198850350918
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14441,83,1.21 [0.91-1.62],0.1917281599189921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14595,237,0.90 [0.75-1.08],0.2490631708921117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,20960,43,1.16 [0.78-1.74],0.4567630003856759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20966,49,0.76 [0.52-1.12],0.1715324037624982
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23360,87,1.26 [0.95-1.68],0.1071845594190586
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23392,112,1.04 [0.81-1.33],0.7808100589745799
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23428,83,1.15 [0.86-1.53],0.3571527323074445
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23490,71,1.18 [0.86-1.62],0.2957696077315557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23210,59,1.05 [0.75-1.48],0.769480816263133
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23245,94,0.89 [0.68-1.17],0.3936876787321441
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22665,114,1.22 [0.95-1.57],0.110745338930189
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22642,91,1.26 [0.96-1.67],0.0984188374088866
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23881,90,1.26 [0.96-1.66],0.1007436232825368
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,23088,537,0.90 [0.80-1.01],0.0713573873313103
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,23117,75,1.01 [0.74-1.37],0.9486131438775068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19579,1840,1.10 [1.03-1.17],0.0055652187559094
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23882,114,1.04 [0.81-1.33],0.7756505457330335
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22659,178,1.03 [0.84-1.25],0.7993454667546847
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22646,165,1.04 [0.85-1.28],0.6991107975881581
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23276,204,1.03 [0.85-1.24],0.7706115973071326
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23272,200,1.04 [0.86-1.25],0.7029421780605705
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23399,487,1.09 [0.96-1.23],0.1841068120738175
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,23017,105,1.18 [0.92-1.53],0.196226505796901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,22983,71,1.28 [0.93-1.75],0.1260314283114844
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23221,309,1.09 [0.94-1.27],0.2634920355360065
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,23032,120,1.02 [0.80-1.31],0.8478713630594739
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11576,57,1.19 [0.83-1.70],0.3432891443187806
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21466,1014,1.11 [1.02-1.21],0.0179460879323522
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,23164,136,1.33 [1.06-1.66],0.0154315642270575
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23181,153,1.20 [0.97-1.49],0.0960923301606686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23181,153,1.20 [0.97-1.49],0.0960923301606686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22248,871,1.09 [0.99-1.19],0.0775610850004803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Asthma,17889,871,1.10 [1.00-1.21],0.0436296284629704
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17728,871,1.10 [1.00-1.21],0.042107532518571
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17877,859,1.09 [1.00-1.20],0.0625581137262038
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23788,77,1.09 [0.81-1.48],0.5673228302261144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,22470,58,1.04 [0.74-1.48],0.8171661891086317
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23851,58,1.05 [0.74-1.48],0.8044738711067065
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22464,52,1.02 [0.71-1.48],0.9110451198803392
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,22475,75,1.02 [0.75-1.38],0.9095658311673472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,22571,171,1.08 [0.88-1.32],0.4487486506141888
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23054,84,1.08 [0.81-1.44],0.5929045540446602
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16714,5249,1.05 [1.00-1.10],0.0444559309803232
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23570,418,1.11 [0.97-1.26],0.1158523435661964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24034,90,1.13 [0.86-1.49],0.3785217476207311
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,24039,81,1.18 [0.88-1.57],0.2742860713400261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,23248,96,1.02 [0.78-1.34],0.8818821379571561
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23262,110,1.23 [0.96-1.57],0.1062902717757239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24025,99,1.15 [0.89-1.50],0.2849118389210489
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23253,101,1.21 [0.93-1.57],0.1460291818389139
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22991,69,0.73 [0.53-1.02],0.0619439107232703
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23946,44,0.70 [0.47-1.06],0.0921332721613646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18213,191,0.93 [0.76-1.13],0.4538544858923229
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20036,2014,1.03 [0.96-1.09],0.4391107037601088
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,18277,255,1.26 [1.06-1.48],0.0070115819890784
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18676,654,1.05 [0.95-1.17],0.3446865222428755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18088,66,1.09 [0.79-1.51],0.6042901204905511
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18143,121,1.32 [1.04-1.68],0.0225934256248205
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18056,34,1.09 [0.69-1.73],0.6998514846079
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,18148,126,0.86 [0.68-1.10],0.2306871397363216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,18088,66,1.10 [0.79-1.53],0.5633505846762441
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23992,51,0.99 [0.68-1.44],0.9517815142806704
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,18137,115,1.03 [0.80-1.32],0.8314162711157543
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18756,734,0.97 [0.87-1.07],0.5272911122080237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,23928,133,1.03 [0.82-1.30],0.7911379787306451
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,18522,500,1.01 [0.89-1.13],0.9316692562615466
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18173,151,1.09 [0.87-1.35],0.4561911116626563
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23948,127,0.89 [0.71-1.13],0.3546436671402231
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,23904,109,0.98 [0.76-1.26],0.8541447012974008
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,21565,1045,1.04 [0.96-1.13],0.3634508946137683
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,20577,57,0.86 [0.60-1.23],0.4128103905051923
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,20586,66,1.22 [0.88-1.70],0.2314994895467393
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,20610,90,0.94 [0.71-1.25],0.6856816771682253
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21357,837,1.08 [0.98-1.18],0.1283196219914284
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23128,799,1.08 [0.98-1.19],0.1019157317077981
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,19100,1906,1.05 [0.98-1.12],0.1372454066961169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23773,58,nan [nan-nan],
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24015,82,1.03 [0.77-1.38],0.8314318878538416
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,22411,82,1.04 [0.78-1.39],0.7910028005424925
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22389,60,0.87 [0.62-1.23],0.4339833768580451
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23939,115,1.17 [0.92-1.50],0.1987031476596374
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,22444,115,1.18 [0.92-1.51],0.1825434686887302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22430,101,1.14 [0.87-1.47],0.3424908474027084
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23008,679,1.09 [0.98-1.21],0.1005460910010248
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22998,669,1.08 [0.98-1.20],0.1249109163531741
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17284,90,1.06 [0.80-1.40],0.6740294357591595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal stricture,23652,90,1.04 [0.79-1.38],0.7614442088892895
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17250,56,1.06 [0.74-1.51],0.7494756447228824
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17781,587,1.06 [0.95-1.19],0.3198560075202024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17403,209,1.06 [0.88-1.27],0.5392166565864001
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17530,336,1.16 [1.00-1.34],0.0489864071209898
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,22606,301,1.12 [0.96-1.31],0.1427652220909901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23625,112,0.86 [0.67-1.11],0.2609259793709008
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17307,113,0.94 [0.74-1.21],0.6536620622241271
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17235,41,0.75 [0.49-1.14],0.1735776557703493
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17977,783,1.03 [0.94-1.14],0.5240065827984595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,17399,205,0.98 [0.81-1.18],0.8341530944008978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23612,99,0.84 [0.64-1.10],0.2098972682007375
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,23391,89,0.74 [0.55-0.99],0.0392026511721776
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,23349,47,0.89 [0.60-1.32],0.5630627815783211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22696,753,1.09 [0.98-1.20],0.0992672193865961
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,22571,628,1.07 [0.96-1.19],0.2317674482884349
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,22056,113,1.25 [0.98-1.60],0.0724534637344711
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21999,56,1.28 [0.90-1.81],0.1698570482824415
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,21994,51,0.90 [0.62-1.32],0.6035168083093658
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23931,51,0.89 [0.61-1.30],0.5485112008490849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22881,258,1.29 [1.10-1.52],0.0021105826526643
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22712,89,nan [nan-nan],
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,22699,76,1.26 [0.93-1.70],0.1304103658622445
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22658,35,1.35 [0.87-2.10],0.1743703086541808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22762,139,1.39 [1.11-1.73],0.0034410412005087
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,22754,131,1.39 [1.11-1.75],0.0041311703700372
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21304,1403,0.97 [0.90-1.05],0.4398418402924369
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23667,102,0.96 [0.73-1.25],0.7438150297642494
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23677,396,1.03 [0.90-1.17],0.7060904577401135
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22676,596,1.01 [0.90-1.13],0.8951074509011425
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23344,289,0.97 [0.83-1.13],0.6873746915387802
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23118,63,0.83 [0.59-1.17],0.2938107413331571
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23241,186,0.97 [0.80-1.18],0.7709616904235264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23808,76,0.88 [0.64-1.19],0.4016619476705939
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23787,55,0.89 [0.62-1.28],0.5375052304702841
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23775,43,0.83 [0.55-1.25],0.3840053831150896
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23843,50,0.88 [0.60-1.29],0.5227667735708144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23840,47,0.87 [0.58-1.29],0.4791867379105434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23334,53,1.28 [0.89-1.84],0.1829764511811585
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23587,306,1.02 [0.87-1.18],0.8245347461783419
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22162,82,0.87 [0.65-1.17],0.3487334508223565
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22213,133,0.88 [0.70-1.12],0.296759938299087
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22176,96,0.94 [0.71-1.23],0.6366945219408313
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22303,223,1.06 [0.88-1.26],0.5449188160370171
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22281,201,1.03 [0.85-1.24],0.7675895846330236
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16942,3854,1.05 [0.99-1.10],0.0882126929040673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18480,2215,1.07 [1.00-1.14],0.0377494089271777
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21605,1172,1.11 [1.03-1.21],0.0080276998221877
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16452,187,1.11 [0.92-1.36],0.2761681312069446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16717,452,1.06 [0.93-1.20],0.4058075128731714
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23567,179,1.14 [0.93-1.39],0.2060794958720198
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23581,164,1.14 [0.92-1.40],0.2305396525248627
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17338,1073,1.12 [1.02-1.22],0.0121303046218143
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19701,1073,1.12 [1.02-1.22],0.0135448896488089
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16277,12,0.59 [0.26-1.36],0.2156630221685203
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23906,12,0.55 [0.24-1.24],0.1507548966261094
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16500,235,1.01 [0.85-1.21],0.8923786525755043
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16343,78,1.02 [0.75-1.39],0.9116613878876272
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16539,274,1.16 [0.98-1.36],0.0840191204795858
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23888,142,1.30 [1.04-1.62],0.0213365028241662
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16682,417,1.13 [0.99-1.30],0.0743233085935919
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16679,414,1.08 [0.94-1.24],0.2622036254377721
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17499,1234,1.05 [0.97-1.14],0.198057064492482
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16365,100,1.18 [0.90-1.53],0.2295121012551079
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16631,366,0.97 [0.84-1.12],0.663787150567777
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16334,69,0.85 [0.61-1.18],0.3246234143322124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16357,92,1.09 [0.83-1.45],0.5288070654050316
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16587,322,1.07 [0.92-1.25],0.3694951817566297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16538,273,1.10 [0.93-1.29],0.2682594789392378
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17929,258,1.13 [0.96-1.34],0.1465671281910373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23328,209,0.96 [0.80-1.15],0.6516398356311293
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23202,83,1.21 [0.90-1.62],0.2035151353008758
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20612,77,1.08 [0.79-1.46],0.6376083449397654
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20808,273,0.96 [0.81-1.13],0.6098469480508706
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21443,908,0.96 [0.88-1.06],0.4399474466958314
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20725,190,0.97 [0.80-1.18],0.7374920779958227
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20605,70,1.06 [0.77-1.46],0.720493224268057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21259,724,0.97 [0.88-1.07],0.5586117492937459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20578,43,1.43 [0.96-2.12],0.0800441152282902
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20752,217,0.98 [0.82-1.18],0.8645905041115185
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20625,90,0.97 [0.73-1.28],0.8154129489807519
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20613,78,0.97 [0.72-1.32],0.859743483231209
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20666,131,0.82 [0.64-1.04],0.0938653707428946
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20605,70,1.10 [0.80-1.51],0.5516073484346917
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20851,316,1.06 [0.91-1.23],0.4306858650410672
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20774,341,1.04 [0.90-1.20],0.6022978622443889
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20498,65,0.94 [0.67-1.31],0.7133535354927965
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20530,97,0.78 [0.59-1.03],0.0853026042334646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20557,124,1.29 [1.02-1.64],0.0318176905908677
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20468,35,1.22 [0.78-1.90],0.3758305328628554
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20484,51,1.34 [0.93-1.93],0.1192475860856717
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20470,37,1.05 [0.68-1.62],0.8339938268176261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20666,233,1.08 [0.90-1.28],0.4163448412929474
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20485,52,1.04 [0.72-1.51],0.8414333009601337
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20491,58,1.06 [0.75-1.51],0.7453076070660969
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20547,114,1.17 [0.92-1.50],0.2067371301224454
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20505,72,0.92 [0.67-1.27],0.6250452694324322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20916,483,1.11 [0.98-1.25],0.1022728625744539
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20604,171,0.97 [0.79-1.19],0.7867486946152916
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20697,264,1.12 [0.95-1.32],0.1761688540710762
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21669,211,0.89 [0.74-1.08],0.2299091492652011
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21875,417,0.84 [0.73-0.96],0.0115747730850556
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21492,34,0.96 [0.61-1.52],0.8749773852156173
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21507,49,0.87 [0.59-1.28],0.4794770526086361
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21550,92,0.80 [0.60-1.06],0.1202087853729052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19751,5369,1.00 [0.96-1.04],0.9433138904295384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22052,157,1.14 [0.93-1.41],0.2154452978937984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21934,39,1.46 [0.96-2.20],0.0737581311252744
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22225,27,1.84 [1.12-3.03],0.0161060538242616
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22229,31,1.25 [0.78-2.01],0.3458524718216593
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22228,30,1.06 [0.65-1.71],0.8262859535131567
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23858,113,0.89 [0.69-1.15],0.3905024623567701
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23766,53,1.13 [0.78-1.62],0.5240328768921119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23829,84,0.93 [0.69-1.24],0.6062366452803972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23778,33,0.86 [0.53-1.37],0.5168729114240962
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22153,1099,1.03 [0.95-1.12],0.4278413376281337
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,21162,108,0.96 [0.74-1.25],0.7762830533813686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21129,75,1.36 [1.01-1.84],0.04401016123731
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21196,142,1.15 [0.92-1.43],0.2186312469161058
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21135,81,0.86 [0.64-1.16],0.3324532768922611
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21922,868,1.05 [0.96-1.15],0.2873095446864546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23799,423,0.92 [0.80-1.04],0.1897339074294854
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23507,131,0.83 [0.66-1.06],0.1317414404499775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23519,143,1.00 [0.80-1.24],0.9751876689288678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23482,106,0.87 [0.67-1.12],0.2750494803943403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23737,489,0.95 [0.84-1.07],0.4030069979406453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23365,117,0.83 [0.65-1.07],0.153888804019638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23464,216,0.99 [0.82-1.18],0.8975612419293837
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21951,4020,1.00 [0.95-1.05],0.9960956234843632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,18240,309,1.11 [0.95-1.29],0.1742957178120748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,18018,87,1.34 [1.01-1.77],0.0433600241190102
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18073,142,1.06 [0.85-1.32],0.6137659550687928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18631,700,1.08 [0.97-1.20],0.1448362942774613
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18284,353,0.93 [0.81-1.08],0.3344849710120073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18766,835,0.97 [0.88-1.06],0.4891464891277944
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18202,271,0.83 [0.71-0.98],0.0288880182897309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18316,385,1.04 [0.90-1.19],0.6094467244794985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,18019,88,1.24 [0.94-1.64],0.1251896799262126
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,18100,169,1.16 [0.95-1.43],0.1444870975563184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",24032,232,1.16 [0.98-1.38],0.0842210129975098
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,24043,220,1.16 [0.97-1.38],0.1105041570105409
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,24064,118,1.20 [0.94-1.53],0.1365411131006131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",24054,130,1.22 [0.97-1.53],0.0931618777923281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18061,130,0.91 [0.72-1.15],0.4311931722986003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18032,101,0.90 [0.69-1.17],0.416345103532614
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18057,126,1.10 [0.87-1.40],0.4147786692033204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Irregular menses,23976,411,1.19 [1.04-1.35],0.0101745105612582
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",19108,1177,1.06 [0.98-1.15],0.1650523094375527
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18696,765,1.01 [0.91-1.11],0.8881276432836783
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",24051,179,1.09 [0.90-1.33],0.3759761998612561
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18340,409,0.89 [0.78-1.02],0.0876190232056718
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18205,274,1.07 [0.91-1.26],0.4053291172756401
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18722,791,0.96 [0.87-1.06],0.4258428869354077
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female infertility,18019,88,1.16 [0.87-1.55],0.310595538960043
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",18012,81,1.12 [0.83-1.52],0.4501317650043005
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,24061,735,1.01 [0.91-1.13],0.7995113276396222
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,24067,1011,1.07 [0.97-1.17],0.1952762424018024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,24061,398,1.14 [0.99-1.31],0.063792772284694
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23775,112,1.26 [0.98-1.62],0.0713931886561394
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23823,160,1.03 [0.83-1.28],0.7582882772222199
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23804,141,1.24 [0.99-1.55],0.0632973148724265
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",24077,144,1.00 [0.79-1.25],0.9663079006553508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,24079,142,0.98 [0.78-1.23],0.8484889318459733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,24076,367,0.92 [0.79-1.06],0.2399219291473597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23818,109,0.72 [0.55-0.94],0.0159587615190932
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23914,205,0.94 [0.78-1.14],0.5472236536686091
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23450,124,1.15 [0.90-1.47],0.2586504357108459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23496,170,0.97 [0.78-1.20],0.7704284565822138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23529,203,1.03 [0.85-1.25],0.7492742975042072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23451,125,0.97 [0.75-1.24],0.7886494665882073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23441,115,1.09 [0.84-1.40],0.5199318621296918
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23453,127,0.84 [0.66-1.08],0.1800923928354743
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,23250,194,1.11 [0.91-1.35],0.2960702883521745
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23434,378,1.00 [0.87-1.16],0.9549389875997292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23614,558,1.09 [0.97-1.24],0.1619968149286528
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",24081,148,1.09 [0.87-1.36],0.4509575815048453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22854,113,1.05 [0.81-1.35],0.7234344012659173
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",23141,85,0.91 [0.68-1.23],0.551005878046111
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,24087,289,0.95 [0.81-1.12],0.5513205371119645
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,24022,224,0.92 [0.77-1.11],0.4085085817498846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",24076,213,1.10 [0.91-1.32],0.3325922356032819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",24066,203,1.11 [0.91-1.34],0.3023760719421904
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23821,42,0.91 [0.60-1.38],0.6632747734263902
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21550,539,0.90 [0.80-1.02],0.0903616437378284
